We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
-5.47%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$3.64B
AUM Growth
-$258M
Cap. Flow
-$28M
Cap. Flow %
-0.77%
Top 10 Hldgs %
31.5%
Holding
1,117
New
20
Increased
149
Reduced
280
Closed
111

Sector Composition

Rank Sector Weight
1 Technology 25.41%
2 Healthcare 21.78%
3 Financials 10.83%
4 Consumer Discretionary 10.02%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WE
1101
DELISTED
WeWork Inc.
WE
0
CEQP
1102
DELISTED
Crestwood Equity Partners LP
CEQP
-207
Closed -$5K
RAD
1103
DELISTED
Rite Aid Corporation
RAD
$0 ﹤0.01%
5
ZYNE
1104
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$0 ﹤0.01%
50
TRTN
1105
DELISTED
Triton International Limited
TRTN
-83
Closed -$4K
SNMP
1106
DELISTED
Evolve Transition Infrastructure LP
SNMP
$0 ﹤0.01%
2
DBD
1107
DELISTED
Diebold Nixdorf Incorporated
DBD
-200
Closed
LYLT
1108
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$0 ﹤0.01%
10
-10
-50% -$26
COUP
1109
DELISTED
Coupa Software Incorporated
COUP
-43
Closed -$2K
ZEN
1110
DELISTED
ZENDESK INC
ZEN
-200
Closed -$15K
CDK
1111
DELISTED
CDK Global, Inc.
CDK
-2,487
Closed -$136K
POTX
1112
DELISTED
Global X Cannabis ETF
POTX
$0 ﹤0.01%
6
ZOM
1113
DELISTED
Zomedica Corp.
ZOM
$0 ﹤0.01%
250

Similar funds

HM Payson & Co's Q3 2022 Portfolio in Review

As of Q3 2022, HM Payson & Co held 1,117 positions worth $3.64B, down 6.6% from $3.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

HM Payson & Co's Q3 2022 filing shows 20 new, 149 increased, 280 reduced and 111 closed positions. Its largest new stake was Invesco BulletShares 2026 Corporate Bond ETF: 658,565 shares worth $12.3M. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $42.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • HM Payson & Co's largest Q3 2022 buy was Invesco BulletShares 2026 Corporate Bond ETF: 658,565 shares worth $12.3M.
  • HM Payson & Co added most to Bristol-Myers Squibb in Q3 2022, an estimated $32.6M increase.
  • HM Payson & Co's biggest Q3 2022 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $42.6M.
  • HM Payson & Co fully exited PIMCO Enhanced Short Maturity Active ESG ETF in Q3 2022, selling an estimated $3.28M.
  • HM Payson & Co's ten largest holdings make up 32% of its $3.64B portfolio in Q3 2022.
  • HM Payson & Co opened 20 new positions and closed 111 in Q3 2022.
  • HM Payson & Co's portfolio value fell 6.6% quarter-over-quarter to $3.64B.

Based on HM Payson & Co's 13F filing for Q3 2022, filed 25 Oct 2022.